As of Mar 24
| -0.0421 / -5.18%|
The 2 analysts offering 12-month price forecasts for Opexa Therapeutics Inc have a median target of 1.00, with a high estimate of 1.00 and a low estimate of 1.00. The median estimate represents a +29.87% increase from the last price of 0.77.
The current consensus among 2 polled investment analysts is to Hold stock in Opexa Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.